Federal Court Postpones Effective Date of Several Provisions in ACA Marketplace Integrity Rule

September 9, 2025

marketplace

On Aug. 22, the U.S. District Court for Maryland issued a decision and order staying (i.e., postponing) various provisions of the recently finalized Affordable Care Act (ACA) Marketplace Integrity and Affordability Final Rule.

The lawsuit, City of Columbus et al. v. Kennedy et al., was filed by a group of municipalities and nonprofit organizations and alleged various provisions of the rule are contrary to law and/or “arbitrary and capricious” under the Administrative Procedures Act (APA). The Court’s decision stays, pending a final ruling, the effective date of six of the eight challenged provisions, including: revision to the de minimis ranges for actuarial value calculations; a $5 monthly penalty for automatic re-enrollees to reconfirm eligibility; a requirement that enrollees pay past due premiums before being enrolled in new coverage; new verification requirements for special enrollment period (SEP) enrollments; a requirement that Exchanges verify household income inconsistencies when a tax filer’s attested projected annual household income differs from “trusted data sources”; and re-instituting the failure-to-reconcile tax data policy.

The Administration has 60 days to appeal. Regardless of the Administration’s decision, resolution could take several months and potentially result in further appeals, with a final decision likely not occurring until sometime next year. We expect that federal and state agencies will provide guidance to carriers in the interim for the 2026 plan year.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like